AAP
MRTX

Ardsley Advisory Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Ardsley Advisory Partners’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,000
Closed -$258K – 160
2019
Q4 		$258K Buy
+2,000
New +$258K 0.04% 104